US Broker Ratings

Replimune Group, Inc. (REPL) Stock Analysis: Evaluating a 59.82% Potential Upside in Oncolytic Immunotherapy

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is pioneering the development of oncolytic immunotherapies designed to activate the immune system against cancer. While its innovative approach to cancer..

Immunome, Inc. (IMNM) Stock Analysis: Exploring a 52.79% Potential Upside with Strong Buy Consensus

Immunome, Inc. (NASDAQ: IMNM), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising therapeutic innovations and a robust consensus of buy ratings. With..

InMode Ltd. (INMD) Stock Analysis: Unveiling an 18.63% Potential Upside in the Medical Devices Sector

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specifically within the medical devices industry, is headquartered in Yokne’am, Israel. Known for its innovative approach to minimally invasive..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Exploring the 136% Potential Upside for Biotech Investors

Gyre Therapeutics, Inc. (NASDAQ: GYRE) is capturing attention in the healthcare sector, particularly among biotechnology investors, due to its promising portfolio and substantial potential upside. With a market capitalization of..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a 47% Revenue Surge Amid Market Challenges

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid industry, is capturing investor attention despite a challenging market landscape. With a notable 47% revenue growth, the company is..

Geron Corporation (GERN) Stock Analysis: Exploring a 101% Potential Upside in Biotech

Geron Corporation (NASDAQ: GERN), a notable player in the biotechnology sector, offers an intriguing investment proposition with a potential upside of 101.18% according to analyst targets. With a current market..

Phibro Animal Health Corporation (PAHC) Stock Analysis: An Investor’s Perspective on Growth Potential and Market Position

Phibro Animal Health Corporation (NASDAQ: PAHC), a significant player in the healthcare sector, specifically in the drug manufacturing of specialty and generic products, is attracting investor attention with its robust..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unveiling a Potential 187.53% Upside in the Biotechnology Sector

In the ever-evolving biotechnology sector, Niagen Bioscience, Inc. (NASDAQ: NAGE) stands out with its innovative approach to healthy aging and a remarkable potential upside of 187.53% based on current analyst..

uniQure N.V. (QURE) Stock Analysis: Navigating a 129.74% Potential Upside in Biotechnology

Investors with a keen eye on the biotechnology sector might find uniQure N.V. (NASDAQ: QURE) an intriguing prospect, particularly considering its potential upside of 129.74%. As a Dutch company specializing..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Growth Amidst Market Volatility

AMN Healthcare Services Inc (NYSE: AMN), a prominent player in the U.S. healthcare sector, stands at a pivotal juncture. Known for its technology-enabled workforce solutions, AMN serves a broad spectrum..

Zymeworks Inc. (ZYME) Stock Analysis: Robust Buy Ratings and Promising Upside Potential

Zymeworks Inc. (ZYME), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to developing biotherapeutics for cancer, inflammation, and autoimmune diseases. With a current..

Arcus Biosciences, Inc. (RCUS) Investor Outlook: Strong Buy Ratings and a 44.98% Upside Potential

Arcus Biosciences, Inc. (NASDAQ: RCUS), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its promising pipeline of cancer therapies and a notably high..

Ardelyx, Inc. (ARDX) Stock Analysis: Analyst Ratings Signal a 156% Upside Potential

Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology company based in Waltham, Massachusetts, has captured the attention of investors with a striking potential upside of 156.37%, according to the latest analyst ratings...

Autodesk, Inc. (ADSK) Stock Analysis: Insight into a 37% Potential Upside with Strong Buy Ratings

Autodesk, Inc. (NASDAQ: ADSK), a titan in the technology sector, specifically within the software application industry, has been capturing investor interest with its robust growth metrics and potential for significant..

Bentley Systems, Inc. (BSY) Stock Analysis: Unlocking a 41% Upside Potential in Infrastructure Software

For investors with a keen eye on the technology sector, Bentley Systems, Incorporated (NASDAQ: BSY) presents a compelling opportunity. Specializing in infrastructure engineering software solutions, Bentley Systems has carved a..

Upbound Group, Inc. (UPBD) Stock Analysis: Unpacking the 50.63% Potential Upside for Investors

Investors looking for a blend of technology innovation and high dividend yields may find Upbound Group, Inc. (NASDAQ: UPBD) an intriguing prospect. This technology and data-driven company, formerly known as..

Workday, Inc. (WDAY) Investor Outlook: A 44% Potential Upside Amid Strong Growth Metrics

Workday, Inc. (NASDAQ: WDAY), a prominent player in the technology sector specializing in enterprise cloud applications, is drawing investor attention with a compelling potential upside of 44.39% from its current..

Similarweb Ltd. (SMWB) Stock Analysis: Unpacking a 73% Potential Upside in the Tech Sector

In the ever-evolving landscape of the technology sector, Similarweb Ltd. (NASDAQ: SMWB) stands out as an intriguing prospect for investors seeking to capitalize on data-driven insights and digital analytics. With..

SAP SE (SAP) Stock Analysis: Exploring a 64.55% Potential Upside for Investors

SAP SE (NYSE: SAP), a giant in the technology sector, is capturing investor interest with its strong position in the software application industry and a promising potential upside of 64.55%...

Intuit Inc. (INTU) Stock Analysis: Unpacking a 53.83% Potential Upside for Investors

Intuit Inc. (NASDAQ: INTU), the technology giant renowned for its software solutions, is currently capturing the attention of investors with a compelling potential upside of 53.83%, according to analyst projections...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds